| Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer (NCT00669162) | University of Kansas Medical Center | 2012-08-01 |
| A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology (NCT01667536) | Molecular Insight Pharmaceuticals, Inc. | 2012-08-01 |
| Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer (NCT01664923) | Pfizer | 2012-08-01 |
| Non-systemic Treatment for Patients With Low-volume Metastatic Prostate Cancer (NCT01558427) | University Hospital, Ghent | 2012-08-01 |
| Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management (NCT01838265) | University of Miami | 2012-08-01 |
| GP Extended Action Triptorelin (NCT01673984) | Ipsen | 2012-08-01 |
| Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations (NCT02020876) | GenomeDx Biosciences Corp | 2012-08-01 |
| Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer (NCT01617161) | Massachusetts General Hospital | 2012-07-25 |
| Pre-Prostatectomy Lovastatin on Prostate Cancer (NCT01478828) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-07-13 |
| MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial (NCT01411345) | University of Miami | 2012-07-12 |
| Functional MRI Use in Prostate Radiation Treatment Planning (NCT01985932) | Abramson Cancer Center at Penn Medicine | 2012-07-01 |
| Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer (NCT01583920) | Sunnybrook Health Sciences Centre | 2012-07-01 |
| Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer Patients (NCT01715064) | University of Guelph-Humber | 2012-07-01 |
| External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer (NCT01603420) | Proton Collaborative Group | 2012-07-01 |
| Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01) (NCT01987193) | University of Florida | 2012-07-01 |
| Mind-Body Health in Uro-Oncology: Research Study (NCT03852030) | Northwestern University | 2012-07-01 |
| Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer (NCT01656161) | Debiopharm International SA | 2012-07-01 |
| 99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404 (NCT01654874) | Molecular Insight Pharmaceuticals, Inc. | 2012-07-01 |
| Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer (NCT01649635) | Sanofi | 2012-07-01 |
| Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100 (NCT01605227) | Exelixis | 2012-07-01 |
| A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer (NCT01756638) | Janssen Research & Development, LLC | 2012-06-06 |
| Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis. (NCT01964638) | NYU Langone Health | 2012-06-01 |
| A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel (NCT01795703) | Janssen Research & Development, LLC | 2012-06-01 |
| SBRT Boost for Unfavorable Prostate Cancer' (NCT02016248) | MemorialCare Health System | 2012-06-01 |
| Sipuleucel-T Manufacturing Demonstration Study (NCT01477749) | Dendreon | 2012-06-01 |
| Treatment of Prostate Cancer With Firmagon® (NCT01710098) | United Clinic Management GmbH | 2012-06-01 |
| Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy (NCT02003417) | UNC Lineberger Comprehensive Cancer Center | 2012-06-01 |
| Immune Monitoring on Sipuleucel-T (NCT02237170) | Icahn School of Medicine at Mount Sinai | 2012-06-01 |
| Technology Based Psychosocial Intervention for Symptom Management and HRQOL in Men Living With Advanced Prostate Cancer (NCT03149185) | Northwestern University | 2012-05-25 |
| Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC) (NCT01499043) | Daiichi Sankyo | 2012-05-25 |
| A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity (NCT01262664) | M.D. Anderson Cancer Center | 2012-05-24 |
| Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis (NCT01441089) | National Cancer Institute (NCI) | 2012-05-21 |
| Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer (NCT01546987) | Radiation Therapy Oncology Group | 2012-05-01 |
| A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer (NCT02341404) | Lidds AB | 2012-05-01 |
| MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer (NCT01566045) | Philips Healthcare | 2012-05-01 |
| Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT01549951) | Millennium Pharmaceuticals, Inc. | 2012-05-01 |
| Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology (NCT02022904) | Duke University | 2012-05-01 |
| Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment (NCT01851018) | CHU de Quebec-Universite Laval | 2012-05-01 |
| Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer (NCT01677845) | NYU Langone Health | 2012-05-01 |
| High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule (NCT01605097) | British Columbia Cancer Agency | 2012-05-01 |
| Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA (NCT01531205) | H. Lee Moffitt Cancer Center and Research Institute | 2012-05-01 |
| A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes (NCT02825225) | University of Nove de Julho | 2012-05-01 |
| XL-184+Abiraterone in Post-Chemo CRPC (NCT01574937) | Dana-Farber Cancer Institute | 2012-04-03 |
| Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State (NCT01560858) | Ipsen | 2012-04-01 |
| C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma (NCT01530269) | Phoenix Molecular Imaging | 2012-04-01 |
| A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer (NCT01940237) | New York State Psychiatric Institute | 2012-04-01 |
| Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer (NCT02107404) | SOTIO a.s. | 2012-04-01 |
| Protection of Rectum From High Radiation Doses (NCT01601691) | University of Oulu | 2012-04-01 |
| Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients (NCT02058680) | OncBioMune Pharmaceuticals | 2012-04-01 |
| GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy (NCT01704274) | Dr. D. Robert Siemens | 2012-04-01 |
| Prostate Hypoxia FAZA (NCT01567800) | University Health Network, Toronto | 2012-04-01 |
| Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy (NCT01446991) | British Columbia Cancer Agency | 2012-04-01 |
| Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer (NCT01672411) | University Of Perugia | 2012-04-01 |
| A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer (NCT01615406) | Molecular Insight Pharmaceuticals, Inc. | 2012-04-01 |
| Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer (NCT01547299) | Pfizer | 2012-03-31 |
| Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer (NCT01591122) | Janssen Research & Development, LLC | 2012-03-27 |
| Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer (NCT02107430) | SOTIO a.s. | 2012-03-01 |
| Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer (NCT01511536) | Sanofi | 2012-03-01 |
| Shear Wave Elastography of Prostate Cancer (NCT02425163) | University of Magdeburg | 2012-03-01 |
| Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer (NCT02107391) | SOTIO a.s. | 2012-03-01 |
| The Efficacy of Pilates in the Recovery of Post-prostatectomy Urinary Incontinence (NCT02086266) | Universidade Estadual de Londrina | 2012-03-01 |
| A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy (NCT01546623) | Takeda | 2012-03-01 |
| Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer (NCT01522443) | Exelixis | 2012-03-01 |
| Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study. (NCT01562522) | Ipsen | 2012-03-01 |
| Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer (NCT01542021) | Memorial Sloan Kettering Cancer Center | 2012-02-24 |
| Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer (NCT01543659) | Memorial Sloan Kettering Cancer Center | 2012-02-21 |
| Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer (NCT01620515) | Nymox Corporation | 2012-02-21 |
| Multi-modality Prostate Cancer Image Guided Interventions (NCT04009174) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2012-02-12 |
| Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy (NCT01410942) | M.D. Anderson Cancer Center | 2012-02-08 |
| AMG 386 and Abiraterone for Advanced Prostate Cancer (NCT01553188) | National Cancer Institute (NCI) | 2012-02-08 |
| Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men (NCT02088164) | National Taiwan University Hospital | 2012-02-01 |
| The Use of Transperineal Ultrasound for Radiation Therapy Treatment Planning and Image Guidance in the Treatment of Prostate Cancer (NCT01545154) | H. James Wallace, MD | 2012-02-01 |
| Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer (NCT01174199) | Roswell Park Cancer Institute | 2012-02-01 |
| Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers (NCT01535898) | Memorial Sloan Kettering Cancer Center | 2012-02-01 |
| Men's Prostate Awareness Church Training (NCT02131779) | University of Maryland, College Park | 2012-02-01 |
| Safety Study of a Shorter (Hypofractionated) Radiotherapy for the Prostate Bed With or Without the Pelvic Lymph Nodes (NCT01620710) | Heidelberg University | 2012-02-01 |
| Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer (NCT01533753) | University of Wisconsin, Madison | 2012-02-01 |
| For Cause Prostate Biopsy in REDUCE Population Trial (NCT01529086) | The Cleveland Clinic | 2012-02-01 |
| Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS) (NCT02224482) | Fox Chase Cancer Center | 2012-02-01 |
| Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy (NCT01812902) | University of Sao Paulo | 2012-02-01 |
| Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer (NCT02105675) | SOTIO a.s. | 2012-02-01 |
| Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer (NCT01565928) | Pfizer | 2012-01-24 |
| Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy (NCT01485861) | Genentech, Inc. | 2012-01-11 |
| Hydroxyethyl Starch and Renal Function After Radical Prostatectomy (NCT01486563) | Regional Hospital Holstebro | 2012-01-01 |
| Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate (NCT01444820) | Sir Mortimer B. Davis - Jewish General Hospital | 2012-01-01 |
| Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer (NCT01514669) | University of Arkansas | 2012-01-01 |
| The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer (NCT01513733) | Andrew J. Armstrong, MD | 2012-01-01 |
| A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values (NCT01553838) | Heinrich-Heine University, Duesseldorf | 2012-01-01 |
| Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer (NCT01491971) | Ferring Pharmaceuticals | 2012-01-01 |
| Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms (NCT01901042) | Federal University of Mato Grosso | 2012-01-01 |
| Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer (NCT01492972) | Proton Collaborative Group | 2012-01-01 |
| Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection (NCT01572701) | Molecular Insight Pharmaceuticals, Inc. | 2012-01-01 |
| SpaceOAR System Pivotal Study (NCT01538628) | Boston Scientific Corporation | 2012-01-01 |
| The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage (NCT01484808) | University Urological Associates Inc. | 2012-01-01 |
| Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate Cancer (NCT02479945) | Abramson Cancer Center at Penn Medicine | 2012-01-01 |
| MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer (NCT01411319) | University of Miami | 2011-12-27 |
| Imaging for Significant Prostate Cancer Risk Evaluation (NCT01492270) | University College London Hospitals | 2011-12-01 |
| Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer (NCT01338012) | Dendreon | 2011-12-01 |
| Imaging of Residual Tumor During Prostatectomy (NCT01173146) | Spectros Corporation | 2011-12-01 |
| Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated (NCT02300389) | The Greater Poland Cancer Centre | 2011-12-01 |